Peripheral blood lymphocyte subsets of newly diagnosed DLBCL patients and their dynamic changes with rituximab based immunochemotherapy

Nicole Selenko, Otto Majdic, Ulrich Jäger, Christian Sillaber, Johannes Stöckl, Walter Knapp, None, Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies? Journal of Clinical Immunology. ,vol. 22, pp. 124- 130 ,(2002) , 10.1023/A:1015463811683

Omayma Alshaarawy, Hosam A. Elbaz, Serum cotinine levels and diabetes mellitus in never smokers. Journal of Diabetes and Its Complications. ,vol. 29, pp. 1032- 1036 ,(2015) , 10.1016/J.JDIACOMP.2015.08.018

Yasuhiro Oki, Kazuhito Yamamoto, Harumi Kato, Yachiyo Kuwatsuka, Hirofumi Taji, Yoshitoyo Kagami, Yasuo Morishima, Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. European Journal of Haematology. ,vol. 81, pp. 448- 453 ,(2008) , 10.1111/J.1600-0609.2008.01129.X

Andreas Rosenwald, George Wright, Wing C. Chan, Joseph M. Connors, Elias Campo, Richard I. Fisher, Randy D. Gascoyne, H. Konrad Muller-Hermelink, Erlend B. Smeland, Jena M. Giltnane, Elaine M. Hurt, Hong Zhao, Lauren Averett, Liming Yang, Wyndham H. Wilson, Elaine S. Jaffe, Richard Simon, Richard D. Klausner, John Powell, Patricia L. Duffey, Dan L. Longo, Timothy C. Greiner, Dennis D. Weisenburger, Warren G. Sanger, Bhavana J. Dave, James C. Lynch, Julie Vose, James O. Armitage, Emilio Montserrat, Armando López-Guillermo, Thomas M. Grogan, Thomas P. Miller, Michel LeBlanc, German Ott, Stein Kvaloy, Jan Delabie, Harald Holte, Peter Krajci, Trond Stokke, Louis M. Staudt, The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma The New England Journal of Medicine. ,vol. 346, pp. 1937- 1947 ,(2002) , 10.1056/NEJMOA012914

Sang Kyun Sohn, Je-Jung Lee, Eun Kyung Cho, Baek-Yeol Ryoo, Ik-Joo Chung, Sung-Soo Yoon, Hyeoung-Joon Kim, Jae Hoon Lee, Hwi-Joong Yoon, Seonyang Park, Soo-Mee Bang, Yeo-Kyeoung Kim, Yeon Hee Park, High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Leukemia & Lymphoma. ,vol. 46, pp. 1599- 1604 ,(2005) , 10.1080/10428190500215191

Bhumsuk Keam, Hyerim Ha, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo, None, Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone Leukemia & Lymphoma. ,vol. 56, pp. 2032- 2038 ,(2015) , 10.3109/10428194.2014.982642

Maria Christina Cox, Italo Nofroni, Luigi Ruco, Rachele Amodeo, Antonella Ferrari, Giacinto La Verde, Patrizia Cardelli, Enrico Montefusco, Esmeralda Conte, Bruno Monarca, Maria Antonietta Aloe-Spiriti, Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma Leukemia & Lymphoma. ,vol. 49, pp. 1745- 1751 ,(2008) , 10.1080/10428190802226425

Martin J. Glennie, Ruth R. French, Mark S. Cragg, Ronald P. Taylor, Mechanisms of killing by anti-CD20 monoclonal antibodies. Molecular Immunology. ,vol. 44, pp. 3823- 3837 ,(2007) , 10.1016/J.MOLIMM.2007.06.151

N Selenko, O Majdic, S Draxler, A Berer, U Jäger, W Knapp, J Stöckl, None, CD20 antibody (C2b8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells Leukemia. ,vol. 15, pp. 1619- 1626 ,(2001) , 10.1038/SJ.LEU.2402226

Zhi-Chun Ding, Lei Huang, Bruce R. Blazar, Hideo Yagita, Andrew L. Mellor, David H. Munn, Gang Zhou, Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy Blood. ,vol. 120, pp. 2229- 2239 ,(2012) , 10.1182/BLOOD-2011-12-398321